Survivorship Care Plans in Research and Practice

被引:169
作者
Salz, Talya [1 ]
Oeffinger, Kevin C. [2 ,3 ]
McCabe, Mary S. [4 ]
Layne, Tracy M. [5 ]
Bach, Peter B. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Adult Long Term Follow Up Program, Dept Pediat, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Adult Long Term Follow Up Program, Dept Med, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Survivorship Program, New York, NY 10065 USA
[5] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA
关键词
BREAST-CANCER-TREATMENT; FOLLOW-UP CARE; LONG-TERM; UNITED-STATES; PHYSICIANS; ADULT; INFORMATION; PERSPECTIVES; SUPPORT; HEALTH;
D O I
10.3322/caac.20142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Institute of Medicine (IOM) recommends the use of survivorship care plans (SCPs) for all cancer survivors. Developing useful SCPs requires understanding what survivors and their providers need and how SCPs can be implemented in practice. Published studies investigating the perspectives of stakeholders (survivors, primary care providers, and oncology providers) were reviewed regarding the content and use of SCPs. All National Cancer Institute (NCI)-designated cancer centers were surveyed concerning the extent to which SCPs for survivors of breast and colorectal cancers are in use, their concordance with the IOM's recommendation, and details about SCP delivery. Survivors and primary care providers typically lack the information the IOM suggested should be included in SCPs. Oncology providers view SCPs favorably but express concerns about the feasibility of their implementation. Fewer than one-half (43%) of NCI-designated cancer centers deliver SCPs to their breast or colorectal cancer survivors. Of those that do, none deliver SCPs that include all components recommended by the IOM. Survivors' and providers' opinions about the use of SCPs are favorable, but there are barriers to implementation. SCPs are not widely used in NCI-designated cancer centers. Variation in practice is substantial, and many components recommended by the IOM framework are rarely included. CA Cancer J Clin 2012;62:101-117. (C) 2012 American Cancer Society.
引用
收藏
页码:101 / 117
页数:17
相关论文
共 62 条
[1]  
American Society of Clinical Oncology, ASCO CANC TREATM SUM
[2]  
American Society of Clinical Oncology, 2007, COL CANC SURV CAR PL
[3]  
American Society of Clinical Oncology, 2008, BREAST CANC SURV CAR
[4]  
[Anonymous], CANC SUPPORT TOPICS
[5]  
[Anonymous], ONCOLIFE SURVIVORSHI
[6]  
[Anonymous], 2008, J ONCOL PRACT, V4, P31
[7]  
[Anonymous], 2004, PRES CANC PAN 2003 2
[8]  
[Anonymous], 2005, CANC PATIENT CANC SU
[9]  
[Anonymous], SURVIVORSHIP CARE PL
[10]  
[Anonymous], FACING FORWARD LIFE